Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
The study found that real-world use of Dexcom ONE CGM led to significant reductions in mean HbA1c levels after 6 months.
A study on digital coaching for obesity found significant weight loss in adults, with a decrease of 6.0 kg at 6 months compared to usual care.
The study evaluated the effects of ertugliflozin on cardiac function in individuals with type 2 diabetes and pre-heart failure, finding significant improvements in certain cardiac metrics.
EWP supplementation improved nutritional status and reduced oxidative stress in diabetic hemodialysis patients.
A family-oriented mHealth intervention including 24 videos on T2D self-management and behavioral techniques.
The AWARD-11 trial compared the effects of Dulaglutide 3.0 mg and 4.5 mg to 1.5 mg on body weight in patients with type 2 diabetes, finding significant weight reductions.
This study evaluated the efficacy and safety of HRS-7535 in adults with type 2 diabetes inadequately controlled with metformin, showing significant reductions in HbA1c and fasting plasma glucose levels.
This study analyzed the long-term cost-effectiveness of IDegLira for treating type 2 diabetes in China, showing significant improvements in glycemic control and health outcomes.
This study investigated the effects of Lactobacillus johnsonii supplementation on blood glucose control in individuals with Type 2 Diabetes and circadian rhythm disruption, finding significant improvements in several metabolic parameters.
A 12-week laughter yoga program was found to be feasible for individuals with type 2 diabetes and demonstrated improvements in glycemic control.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
